Multiple cytokine and growth factor serum biomarkers predict therapeutic response and survival in advanced-stage head and neck cancer patients

Clinical Cancer Research

Volumn 13, Issue 11, 2007, Pages 3107-3108

  Bigbee, William L ^a   Grandis, Jennifer R ^a   Siegfried, Jill M ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; SCATTER FACTOR; VASCULOTROPIN;

ADVANCED CANCER; CANCER GROWTH; CANCER STAGING; CYTOKINE RELEASE; DISEASE FREE SURVIVAL; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; IMMUNOASSAY; METASTASIS; NOTE; ONCOGENE; PRIORITY JOURNAL; STROMA CELL; SURVIVAL; TREATMENT RESPONSE; TUMOR CELL;

CHEMOKINES; CYTOKINES; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOASSAY; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASM METASTASIS; PROGNOSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 34250666217     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0746     Document Type: Note

References (31)

1. Allen C, Duffy S, Teknos T, et al. NF-κB-related serum factors as longitudinal biomarkers of response and survival in advanced oropharyngeal carcinoma. Clin Cancer Res 2007;13:3182-90.
2. Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001;264:169-84.
3. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29:15-8.
4. Richmond A. Nf-κB, chemokine gene transcription and tumour growth. Nat Rev Immunol 2002;2:664-74.
5. Dong G, Loukinova E, Chenz, et al. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-κB signal pathway. Cancer Res 2001;61:4797-808.
6. Wang J, Xi L, Hunt J, et al. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res 2004;64:1861-6.
7. Cohen RF, Contrino J, Spiro JD, Mann EA, Chen LL, Kreutzer DL. Interleukin-8 expression by head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1995;121:202-9.
8. Richards BL, Eisma RJ, Spiro JD, Lindquist RL, Kreutzer DL. Coexpression of IL-8 receptors in head and neck squamous cell carcinoma. Am J Surg 1997;174:507-12.
9. Chen Z, Malhotra PS, Thomas GR, et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 1999;5:1369-79.
10. Homer JJ, Greenman J, Stafford ND. Circulating angiogenic cytokines as tumour markers and prognostic factors in head and neck squamous cell carcinoma. Clin Otolaryngol 2000;27:32-7.
11. Van Waes C, Chen Z, Callister M, et al. Cytokines in immune pathogenesis and therapy of head and neck cancer. In: Veldman JE, Passali D, Lim DJ, editors. Frontiers in immunobiology. The Hague (Netherlands): Kugler Publications; 2000. p. 233-43.
12. Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC, Van Waes C. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res 2001;61:5911-8.
13. Kawano T, Shunsuke Y, Nishimura G, Tsukuda M. The inhibitory effects of TNP 470 on tumour growth of head and neck carcinoma cell producing IL-8. J Laryngol Otol 2001;115:802-7.
14. Shang ZJ, Li JR, Li ZB. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2002;31:495-8.
15. Kuhn DJ, Smith DM, Pross S, et al. Overexpression of interleukin-2 receptor a in a human squamous cell carcinoma of the head and neck cell line is associated with increased proliferation, drug resistance, and transforming ability. J Cell Biochem 2003;89:824-36.
16. Druzgal CH, Chen Z, Yeh NT, et al. A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma. Head Neck 2005;27:771-84.
17. Gokhale AS, Haddad RI, Cavacini LA, et al. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck. Oral Oncol 2005;41:70-6.
18. Riedel F, Zaiss I, Herzog D, Gotte K, Naim R, Hormann K. Seru mlevels of interleukin-6 in 17 patients with primary head and neck squamous cell carcinoma. Anticancer Res 2005;25:2761-5.
19. Teknos TN, Cox C, Yoo S, et al. Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma. Head Neck 2002;24:1004-11.
20. Riedel F, Gotte K, Schwalb J, Wirtz H, Bergler W, Hormann K. Serum levels of vascular endothelial growth factor in patients with head and neck cancer. Eur Arch Otorhinolaryngol 2000;257:332-6.
21. Sato M, Yoshida H, Yanagawa T, et al. Interferon activity and its characterization in the sera of patients with head and neck cancer. Cancer 1984;54:1239-51.
22. Gallo O, Gori AM, Attanasio M, et al. Interleukin-6 and acute-phase proteins in head and neck cancer. Eur Arch Otorhinolaryngol 1995;252:159-62.
23. Avradopoulos K, Mehta S, Blackinton D, et al. Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck. Ann Surg Oncol 1997;4:184-90.
24. Wang YF, Chang SY, Tai SK, et al. Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma. Head Neck 2002;24:850-8.
25. Carson RT, Vignali DA. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods 1999;227:41-52.
26. Kellar KL, Douglass JP. Multiplexed microsphere-based flow cytometric immunoassays for human cytokines. J Immunol Methods 2003;279:277-85.
27. Hathaway B, Landsittel DP, Gooding W, et al. Multiplexed analysis of serum cytokines as biomarkers in squamous cell carcinoma of the head and neck patients. Laryngoscope 2005;115:522-7.
28. Khan KN, Masuzaki H, Fujishita A, et al. Interleukin-6- and tumour necrosis factor α-mediated expression of hepatocyte growth factor by stromal cells and its involvement in the growth of endometriosis. Human Reprod 2005;20:2715-23.
29. Cohen M, Marchand-Adam S, Lecon-Malas V, et al. HGF synthesis in human lung fibroblasts is regulated by oncostatin M. Am J Physiol Lung Cell Mol Physiol 2006;290:1097-103.
30. Dong G, Lee TL, Yeh NT, Geoghegan J, Van Waes C, Chen Z. Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor. Oncogene 2004;23:6199-208.
31. Ren Y, Cao B, Law S, et al. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin Cancer Res 2005;11:6190-7.